Pacira BioSciences (PCRX) Stock Soars 44% on Deal News

Shares of Pacira BioSciences Inc. (PCRX) rose 44.4% to $36.39 in the session of Friday, October 9, on volume of 28.90M shares.

The move came as Barrons.com reported: Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition.

What the GTA data shows

• Options: 25 calls vs. 333 puts traded (put/call 13.32), with $2,019 in call premium and $2,127 in puts.
• Insiders (90 days): $0 bought and $289K sold in SEC Form 4 filings.
• Market value: about $1.5B · Health Care.

Want more breaking news like this the moment it happens? Register for a free 7-day trial at Global Traders Academy →

Written by the GTA Research Desk from GTA Terminal data. Not investment advice.